Table 4 The second ATC Classification level Alimentary tract and metabolism drugs besides Anti-inflammatory and antirheumatic products used by patients with GERD
Drug class | Total n = 2325 (100%) | Men n (%; 95% CI) | Women n (%; 95% CI) | 60 years and older n (%; 95% CI) |
|---|---|---|---|---|
A02 | 921 (39.6) | 332 (39.3; 36.1–42.7) | 589 (39.7; 37.2–42.2) | 308 (45.5; 41.7–49.3) |
M01 | 253 (10.8) | 77 (9.1; 7.4–11.2) | 176 (11.8; 10.3–13.6) | 138 (20.4; 17.4–23.4) |
A10 | 140 (6.0) | 28 (3.32; 2.3–4.7) | 112 (7.5; 6.3- 9.0) | 66 (9.7; 7.6–11.9) |
A11 | 66 (2.8) | 3 (0.35; 0.2–1.1) | 63 (4.25; 3.33–5.4) | 20 (3.0; 1.9–4.5) |
Aot | 38 (1.63) | 17 (2.0; 1.3–3.3) | 21 (1.4; 1.0-2.2) | 9 (1.3; 0.7–2.6) |
A06 | 16 (0.7) | 9 (1.0; 0.5- 2.0) | 7 (0.4; 0.2–0.9) | 8 (1.1; 0.5–2.3) |
A12 | 14 (0.6) | 2 (0.23; 0.1- 1.0) | 12 (0.8; 0.5–1.5) | 5 (0.7; 0.3–1.7) |